Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126282361 | 12628236 | 1 | I | 20160709 | 0 | 20160805 | 20160805 | DIR | 68.00 | YR | F | N | 184.00000 | LBS | 20160722 | N | OT | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126282361 | 12628236 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 395 MG Q 28 DAYS IV | D | D | 0 | 395 | MG | ||||||
| 126282361 | 12628236 | 2 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 61 MG Q 28 DAYS IV | D | D | 0 | 61 | MG | ||||||
| 126282361 | 12628236 | 3 | C | EVEROLIMUS | EVEROLIMUS | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 4 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 6 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 8 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 10 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 12 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 14 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 16 | C | INSULIN PUMP | INSULIN NOS | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 18 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 20 | C | QUNIAPRIL | 2 | 0 | |||||||||||||
| 126282361 | 12628236 | 22 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 24 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 26 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 28 | C | CARAFATE | SUCRALFATE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 30 | C | HYDROCORTISONE CREAM | HYDROCORTISONE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 32 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126282361 | 12628236 | 34 | C | MARINOL | DRONABINOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126282361 | 12628236 | 1 | Malignant peritoneal neoplasm |
| 126282361 | 12628236 | 2 | Malignant peritoneal neoplasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126282361 | 12628236 | HO |
| 126282361 | 12628236 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126282361 | 12628236 | Acute kidney injury | |
| 126282361 | 12628236 | Dizziness | |
| 126282361 | 12628236 | Hypoglycaemia | |
| 126282361 | 12628236 | Lethargy | |
| 126282361 | 12628236 | Loss of consciousness | |
| 126282361 | 12628236 | Malignant neoplasm progression | |
| 126282361 | 12628236 | Orthostatic hypotension | |
| 126282361 | 12628236 | Peritoneal carcinoma metastatic | |
| 126282361 | 12628236 | Septic shock | |
| 126282361 | 12628236 | Unresponsive to stimuli | |
| 126282361 | 12628236 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126282361 | 12628236 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126282361 | 12628236 | 1 | 20160210 | 20160628 | 0 | |
| 126282361 | 12628236 | 2 | 20160210 | 20160628 | 0 |